Compare Stocks › HCA vs NVDA

HCA Healthcare, Inc. (HCA) vs NVIDIA Corporation (NVDA): Which Is the Better Buy in 2026?

As of 2026-11-01, HCA is overvalued at $473, with a DCF intrinsic value of $297 and a margin of safety of -59%. NVDA is overvalued at $205, with an intrinsic value of $163 and a margin of safety of -25%. Of the two, NVDA has the wider margin of safety.

HCA
HCA Healthcare, Inc.
$473.19
VS
NVDA
NVIDIA Corporation
$204.64

Rewards

HCA
  • ★HCA Healthcare, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • ★HCA Healthcare, Inc. scores 95/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
  • ★Free cash flow has grown at a 23.1% CAGR over the past 4 years, demonstrating strong earnings power growth.
NVDA
  • ★NVIDIA Corporation has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 74.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★Free cash flow has grown at a 193.9% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

HCA
  • ⚠FCF yield of 7.8% suggests reasonable valuation assuming continued moderate growth.
NVDA
  • ⚠FCF yield of 2.0% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • ⚠Beneish M-Score of -1.06 flags financial patterns consistent with potential earnings manipulation — warrants further investigation.

Key Valuation Metrics

Learn more →
HCA
NVDA
Valuation
$7.69B
Free Cash Flow
$96.68B
7.78%
FCF Yield
1.96%
15.69
Trailing P/E
25.87
15.16
Forward P/E
12.86
Quality & Moat
17.59%
ROIC
59.19%
N/A
ROE
117.21%
42.76%
Gross Margin
74.67%
1.43
PEG Ratio
0.25
Balance Sheet Safety
N/A
Net Debt / Equity
Net cash
N/A
Interest Coverage
N/A
3.26
Net Debt / EBITDA
-0.12
0.66%
Dividend Yield
0.49%
HCA: 3Ties: 1NVDA: 6
HCANVDA

Historical Fundamentals

Learn more →
HCA

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

NVDA

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
HCA
$2.43
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$15.76B
Δ Market Cap
+$38.30B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
NVDA
$17.02
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$220.50B
Δ Market Cap
+$3.75T
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
HCA
59.3% Overvalued
Price is 59.3% above estimated fair value
Current Price: $473.19
Fair Value: $297.02
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
NVDA
46.0% Margin of Safety
Price is 46.0% below estimated fair value
Current Price: $204.64
Fair Value: $378.65
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
HCA

What growth rate is the market pricing in at $473?

+9.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +7.4%

The market implies +9.1% Owner Earnings growth, roughly in line with history — reasonably priced.

Standard FCF implies +7.4%, reflecting ongoing growth investment.

NVDA

What growth rate is the market pricing in at $205?

+17.5%
Market-Implied Owner Earnings Growth
Standard FCF implies +20.4%

The market implies +17.5% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +20.4%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
HCA
95/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
NVDA
69/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with roic consistency as the key competitive advantage. Improving revenue predictability would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
HCA
-2.78
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
NVDA
-1.06
Likely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
HCA
Insiders 17.2%Institutions 81.5%Retail & Other 1.3%
No. of Institutional Holders1,878
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
NVDA
Insiders 4.0%Institutions 71.5%Retail & Other 24.5%
No. of Institutional Holders7,728
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
HCA
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
NVDA
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
HCA
0
Sells (3M)
6
Sells (12M)
Total value (12M): $31.12M
MCALEVEY MICHAEL R.
Officer
$903,537
@ $533.37 · 2026-02-18
BERRES JENNIFER
Officer
$4.13M
@ $514.58 · 2026-02-11
WYATT CHRISTOPHER F
Officer
$2.02M
@ $505.00 · 2026-02-11
CUFFE MICHAEL S
Officer
$747,135
@ $498.09 · 2026-02-03
HAZEN SAMUEL N
Chief Executive Officer
$21.48M
@ $501.04 · 2026-02-03
MCALEVEY MICHAEL R.
Officer
$1.84M
@ $473.79 · 2025-11-05
CUFFE MICHAEL S
Officer
$1.61M
@ $418.84 · 2025-09-08
FOSTER JON MARK
Officer
$5.80M
@ $369.32 · 2025-05-13
BERRES JENNIFER
Officer
$3.08M
@ $322.59 · 2025-02-14
WHALEN KATHLEEN M
Officer
$527,677
@ $357.99 · 2024-11-14
AKDAMAR EROL R
Officer
$1.02M
@ $353.00 · 2024-11-14
BILLINGTON PHILLIP G
Officer
$1.36M
@ $350.00 · 2024-11-14
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
NVDA
0
Sells (3M)
7
Sells (12M)
Total value (12M): $24.72M
DABIRI JOHN O
Director
$133,750
@ $214.00 · 2026-05-27
ROBERTSON DONALD F JR
Officer
$942,944
@ $174.75 · 2026-03-20
SHAH AARTI S
Director
$3.36M
@ $176.71 · 2026-03-19
DABIRI JOHN O
Director
$555,440
@ $184.90 · 2026-03-13
ROBERTSON DONALD F JR
Officer
$15.19M
@ $189.85 · 2026-01-02
ROBERTSON DONALD F JR
Officer
$4.43M
@ $179.98 · 2025-12-19
DABIRI JOHN O
Director
$112,317
@ $179.42 · 2025-11-24
HUANG JEN-HSUN
Chief Executive Officer
$5.20M
@ $207.91 · 2025-10-29
HUANG JEN-HSUN
Chief Executive Officer
$23.56M
@ $188.47 · 2025-10-28
HUANG JEN-HSUN
Chief Executive Officer
$40.73M
@ $181.04 · 2025-10-23
HUANG JEN-HSUN
Chief Executive Officer
$41.06M
@ $182.48 · 2025-10-20
HUANG JEN-HSUN
Chief Executive Officer
$41.34M
@ $183.73 · 2025-10-15
HUANG JEN-HSUN
Chief Executive Officer
$42.89M
@ $190.60 · 2025-10-10
HUANG JEN-HSUN
Chief Executive Officer
$42.05M
@ $186.89 · 2025-10-07
HUANG JEN-HSUN
Chief Executive Officer
$42.09M
@ $187.08 · 2025-10-02
HUANG JEN-HSUN
Chief Executive Officer
$40.23M
@ $178.82 · 2025-09-29
HUANG JEN-HSUN
Chief Executive Officer
$40.21M
@ $178.69 · 2025-09-24
ROBERTSON DONALD F JR
Officer
$617,298
@ $176.37 · 2025-09-19
HUANG JEN-HSUN
Chief Executive Officer
$39.18M
@ $174.14 · 2025-09-19
HUANG JEN-HSUN
Chief Executive Officer
$39.75M
@ $176.66 · 2025-09-16
HUANG JEN-HSUN
Chief Executive Officer
$39.28M
@ $174.59 · 2025-09-11
HUANG JEN-HSUN
Chief Executive Officer
$38.01M
@ $168.95 · 2025-09-08
HUANG JEN-HSUN
Chief Executive Officer
$38.61M
@ $171.60 · 2025-09-03
HUDSON BEACH DAWN E
Director
$15.38M
@ $170.90 · 2025-09-03
HUANG JEN-HSUN
Chief Executive Officer
$27.12M
@ $180.79 · 2025-08-15
HUANG JEN-HSUN
Chief Executive Officer
$40.96M
@ $182.04 · 2025-08-13
HUANG JEN-HSUN
Chief Executive Officer
$40.66M
@ $180.70 · 2025-08-08
HUANG JEN-HSUN
Chief Executive Officer
$39.78M
@ $176.80 · 2025-08-05
HUANG JEN-HSUN
Chief Executive Officer
$40.18M
@ $178.58 · 2025-07-31
HUANG JEN-HSUN
Chief Executive Officer
$39.16M
@ $174.02 · 2025-07-28
HUANG JEN-HSUN
Chief Executive Officer
$38.22M
@ $169.87 · 2025-07-23
HUANG JEN-HSUN
Chief Executive Officer
$38.71M
@ $172.05 · 2025-07-18
HUANG JEN-HSUN
Chief Executive Officer
$37.59M
@ $167.08 · 2025-07-15
HUANG JEN-HSUN
Chief Executive Officer
$36.43M
@ $161.91 · 2025-07-10
HUANG JEN-HSUN
Chief Executive Officer
$35.55M
@ $158.02 · 2025-07-07
HUANG JEN-HSUN
Chief Executive Officer
$35.16M
@ $156.27 · 2025-07-01
HUANG JEN-HSUN
Chief Executive Officer
$30.47M
@ $152.33 · 2025-06-26
HUANG JEN-HSUN
Chief Executive Officer
$14.40M
@ $144.04 · 2025-06-23
ROBERTSON DONALD F JR
Officer
$646,469
@ $143.66 · 2025-06-20
DABIRI JOHN O
Director
$91,608
@ $138.80 · 2025-05-30
BURGESS ROBERT KENNETH
Director
$6.74M
@ $134.82 · 2025-05-30
KRESS COLETTE M.
Chief Financial Officer
$7.79M
@ $116.83 · 2025-03-21
ROBERTSON DONALD F JR
Officer
$525,585
@ $116.80 · 2025-03-21
SHAH AARTI S
Director
$2.37M
@ $118.42 · 2025-03-20
BURGESS ROBERT KENNETH
Director
$6.16M
@ $115.49 · 2025-03-13
DABIRI JOHN O
Director
$292,930
@ $110.00 · 2025-03-10
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
HCA
FearGreed
😐Neutral(55/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
NVDA
FearGreed
😐Neutral(48/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
HCA
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (55)
NVDA
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (48)
View HCA Full AnalysisView NVDA Full Analysis

Frequently Asked Questions: HCA vs NVDA

Is HCA Healthcare, Inc. or NVIDIA Corporation more undervalued in 2026?▼

Based on our discounted cash flow model, NVDA trades at a -25.5% margin of safety (intrinsic value $163 vs. price $205), compared to HCA's -59.3% margin of safety (intrinsic $297 vs. $473).

Which stock has a wider economic moat, HCA Healthcare, Inc. or NVIDIA Corporation?▼

HCA scores 95/100 (Wide moat), while NVDA scores 69/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is HCA Healthcare, Inc. in financial distress?▼

HCA's Altman Z-Score of 2.7 places it in the Grey zone, signaling elevated bankruptcy risk. NVDA scores 4.7 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, HCA Healthcare, Inc. or NVIDIA Corporation?▼

HCA Healthcare, Inc. (HCA) generates a 7.8% free cash flow yield, compared to NVIDIA Corporation's 2.0%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, HCA Healthcare, Inc. or NVIDIA Corporation?▼

NVDA earns 59.2% ROIC versus HCA's 17.6%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, HCA Healthcare, Inc.'s or NVIDIA Corporation's?▼

HCA's dividend earns a safety score of 94/100 (Very Safe), compared to NVDA's 91/100 (Very Safe). HCA has raised its dividend for 3 consecutive years.

Does NVIDIA Corporation have accounting red flags?▼

NVDA's Beneish M-Score of -1.1 flags it as a likely earnings manipulator (above the -1.78 threshold). By contrast, HCA scores -2.8, within the normal range. The Beneish model detects aggressive accounting through eight financial ratios.

HCA vs NVDA: Which Is the Better Buy in 2026? | SafetyMargin.io